Results 251 to 260 of about 4,179,804 (295)
Some of the next articles are maybe not open access.
AJN, American Journal of Nursing, 1975
Pap smears. Our clinic has provided services previously inaccessible to many women in the community. Colposcopy is a technique which has been used in Europe for many years, but it is relatively new in the United States. The colposcope is a binocular microscope with a magnification of x13.5 and a light source of high intensity. With this instrument, the
C, Milligan, D, Cummings, V, Williamson
openaire +2 more sources
Pap smears. Our clinic has provided services previously inaccessible to many women in the community. Colposcopy is a technique which has been used in Europe for many years, but it is relatively new in the United States. The colposcope is a binocular microscope with a magnification of x13.5 and a light source of high intensity. With this instrument, the
C, Milligan, D, Cummings, V, Williamson
openaire +2 more sources
Obstetrical & Gynecological Survey, 1996
It is well accepted that conscientious and widespread use of cervical cytology will significantly decrease the incidence and mortality rates of cervical cancer. The Papanicolaou smear for cervical cytology fulfills all the criteria for an ideal screening test.
openaire +4 more sources
It is well accepted that conscientious and widespread use of cervical cytology will significantly decrease the incidence and mortality rates of cervical cancer. The Papanicolaou smear for cervical cytology fulfills all the criteria for an ideal screening test.
openaire +4 more sources
The Lancet, 1998
World-wide, there are estimated to be almost half a million new cases and a quarter of a million deaths from cervical cancer each year, accounting for about 10% of all female cancers (Parkin, 2001) and making cervix cancer the second commonest cancer among women, being exceeded only by breast cancer (Table 1). The cumulative incidence rate up to age 74
J, Cuzick, C J, Meijer, J M, Walboomers
openaire +2 more sources
World-wide, there are estimated to be almost half a million new cases and a quarter of a million deaths from cervical cancer each year, accounting for about 10% of all female cancers (Parkin, 2001) and making cervix cancer the second commonest cancer among women, being exceeded only by breast cancer (Table 1). The cumulative incidence rate up to age 74
J, Cuzick, C J, Meijer, J M, Walboomers
openaire +2 more sources
Cervical Cancer Screening: A Review
Obstetrical & Gynecological Survey, 2023(Abstracted from JAMA 2023;330(6):547–558) More than 90% of cervical cancer is caused by persistent infections with carcinogenic human papillomavirus (HPV), leading to precancer and then to cervical cancer. Approximately 100,000 people are treated for cervical precancer, 14,000 people are diagnosed with cervical cancer, and more than 4000 die
Rebecca B, Perkins +3 more
openaire +2 more sources
Science, 2000
The Policy Forum by Cain and Howett ([1][1]) has helped initiate a dialogue on whether human papillomavirus (HPV) testing should be incorporated into cervical cancer screening programs. We are concerned, however, that certain statements in the article are potentially misleading.
T C, Wright +3 more
openaire +2 more sources
The Policy Forum by Cain and Howett ([1][1]) has helped initiate a dialogue on whether human papillomavirus (HPV) testing should be incorporated into cervical cancer screening programs. We are concerned, however, that certain statements in the article are potentially misleading.
T C, Wright +3 more
openaire +2 more sources
The Lancet, 1987
This chapter considers screening for cancer of the cervix from the point of view of routine screening and its applicability as a public health policy. Sensitivity is an essential indicator in the comparison of several competing tests. Currently, convincing evidence on sensitivity of screening for cervix cancer is with the Pap smear.
N E, Day, M, Hakama
openaire +2 more sources
This chapter considers screening for cancer of the cervix from the point of view of routine screening and its applicability as a public health policy. Sensitivity is an essential indicator in the comparison of several competing tests. Currently, convincing evidence on sensitivity of screening for cervix cancer is with the Pap smear.
N E, Day, M, Hakama
openaire +2 more sources
Surgical Oncology Clinics of North America, 2005
Cervical cytology has proved to be one of the most successful examples of cancer screening and has resulted in significant decreases in incidence and mortality from invasive cervical cancer in regions in which comprehensive programs have been instituted.
Kevin, Holcomb, Carolyn D, Runowicz
openaire +2 more sources
Cervical cytology has proved to be one of the most successful examples of cancer screening and has resulted in significant decreases in incidence and mortality from invasive cervical cancer in regions in which comprehensive programs have been instituted.
Kevin, Holcomb, Carolyn D, Runowicz
openaire +2 more sources
Clinical Obstetrics & Gynecology, 2018
Cervical cancer screening has significantly reduced the incidence of cervical cancer in the United States. National recommendations have evolved to keep pace with advancement in our understanding of human papilloma virus (HPV) biology as well as improvements in HPV testing.
openaire +2 more sources
Cervical cancer screening has significantly reduced the incidence of cervical cancer in the United States. National recommendations have evolved to keep pace with advancement in our understanding of human papilloma virus (HPV) biology as well as improvements in HPV testing.
openaire +2 more sources
Annals of Internal Medicine, 1990
Indirect evidence indicates that cervical cancer screening should reduce the incidence and mortality of invasive cervical cancer by about 90%. In the absence of screening, a 20-year-old average-risk woman has about a 250 in 10,000 chance of developing invasive cervical cancer during the rest of her life, and about a 118 in 10,000 chance of dying from ...
openaire +2 more sources
Indirect evidence indicates that cervical cancer screening should reduce the incidence and mortality of invasive cervical cancer by about 90%. In the absence of screening, a 20-year-old average-risk woman has about a 250 in 10,000 chance of developing invasive cervical cancer during the rest of her life, and about a 118 in 10,000 chance of dying from ...
openaire +2 more sources
Ca-A Cancer Journal for Clinicians